Global Randomization And Trial Supply Management Rtsm Market
市场规模(十亿美元)
CAGR :
%

![]() |
2022 –2029 |
![]() |
USD 0.17 Billion |
![]() |
USD 0.52 Billion |
![]() |
|
![]() |
|
>Global Randomization and Trial Supply Management (RTSM) Market, By Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions), Clinical Trial Phase (Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV Clinical Trials), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, Academic Research Institutes) – Industry Trends and Forecast to 2029
Market Analysis and Size
Randomization and trial supply management is abbreviated as RTSM. It's a technology solution that's utilised in clinical studies to manage drug distribution and control patient randomization. Randomization is an experimental control strategy that eliminates selection and unintentional bias.
Data Bridge Market Research analyses that the randomization and trial supply management (RTSM) market which was USD 0.17 billion in 2021, would rocket up to USD 0.52 billion by 2029, and is expected to undergo a CAGR of 15 % during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
Report Metric |
Details |
Forecast Period |
2022 to 2029 |
Base Year |
2021 |
Historic Years |
2020 (Customizable to 2014 - 2019) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premise) Solutions, Cloud-Based (SaaS) Solutions), Clinical Trial Phase (Phase I Clinical Trials, Phase II Clinical Trials, Phase III Clinical Trials, Phase IV Clinical Trials), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, Academic Research Institutes) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
MEDICAL Information Technology Inc. (U.S), SAP (Germany), CPSI (U.S), Meta (U.S), Elinext (U.S), EPIC Systems Corporation (U.S), INFOR (U.S), Cognizant (U.S), Oracle (U.S), Jag products LLC (U.S), Allscripts Healthcare LLC (U.S), Optum Inc. (U.S), Cerner Corporation (U.S), Change Healthcare (U.S), Koninklijke Philips N.V. (Netherlands), athenahealth (U.S), eClinicalWorks (U.S) |
Market Opportunities |
|
Market Definition
Clinical studies use telephone and interactive voice response (IVR) technologies to manage randomization, study medication administration, and inventories using randomization and trial supply management (RTSM) systems.
Randomization and Trial Supply Management (RTSM) Market Dynamics
Drivers
- Rise in adoption of novel software solutions
Increasing adoption of novel software solutions, rising government funding for clinical trials, the introduction of e-clinical solutions to improve data standardisation, and rising pharmaceutical company expenditure for drug development pipeline allocation are some of the factors that will likely accelerate the growth of the randomization and trial supply management (RTSM) market, in the forecast period of 2022-2029.
- increasing number of clinical trials
The increasing number of clinical trials in developing economies, as well as the outsourcing of clinical trial operations by many sectors, would enhance numerous opportunities for the randomization and trial supply management (RTSM) market throughout the forecast period.
Opportunities
Rising awareness among the patients regarding the prevailing advantages of management solutions will help in boosting lucrative opportunities in the growth of the market.
Restraints/Challenges
Lack of skilled professionals and high cost of implementation which will hamper the growth of the randomization and trial supply management (RTSM) market in the forecast period of 2022 to 2029.
This randomization and trial supply management (RTSM) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the randomization and trial supply management (RTSM) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 impact on Randomization and Trial Supply Management (RTSM) Market
The global market for clinical trials has been significantly impacted by the COVID-19 pandemic, since there has been a growing focus on creating novel treatments or vaccinations to combat or treat the disease. COVID-19 has also caused a modest alteration in the way clinical studies are conducted. Previously, there had been a surge in interest in virtual/decentralized trials in the worldwide clinical trials.
Global Randomization and Trial Supply Management (RTSM) Market Scope
The randomization and trial supply management (RTSM) market is segmented on the basis of delivery mode, clinical trial phase and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Delivery Mode
- Web-Hosted (On-Demand) Solutions
- Licensed Enterprise (On-Premise) Solutions
- Cloud-Based (SaaS) Solutions
Clinical Trial Phase
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV Clinical Trials
End-User
- Pharmaceutical
- Biopharmaceutical Companies
- Contract Research Organizations
- Consulting Service Companies
- Medical Device Manufacturers
- Hospitals
- Academic Research Institutes
Randomization and Trial Supply Management (RTSM) Market Regional Analysis/Insights
The randomization and trial supply management (RTSM) market is analysed and market size insights and trends are provided by country, delivery mode, clinical trial phase and end-user as referenced above.
The countries covered in the randomization and trial supply management (RTSM) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the randomization and trial supply management (RTSM) market due to the growing occurrences of lifestyle diseases along with growing population and prevalence of improved infrastructure.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the prevalence of targeted diseases along with rising number of clinical trials.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Randomization and Trial Supply Management (RTSM) Market Share Analysis
The randomization and trial supply management (RTSM) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to randomization and trial supply management (RTSM) market.
Some of the major players operating in the randomization and trial supply management (RTSM) market are:
- MEDICAL Information Technology Inc. (U.S)
- SAP (Germany)
- CPSI (U.S)
- Meta (U.S)
- Elinext (U.S)
- EPIC Systems Corporation (U.S)
- INFOR (U.S)
- Cognizant (U.S)
- Oracle (U.S)
- Jag products LLC (U.S)
- Allscripts Healthcare LLC (U.S)
- Optum Inc. (U.S)
- Cerner Corporation (U.S)
- Change Healthcare (U.S)
- Koninklijke Philips N.V. (Netherlands)
- athenahealth (U.S)
- eClinicalWorks (U.S)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。